Cardiovascular disease: rise, fall, and future prospects.
about
Sulforaphane Protects against Cardiovascular Disease via Nrf2 ActivationCardiovascular risk in Mozambique: who should be treated for hypertension?The Challenge of Cardiovascular Diseases and Diabetes to Public Health: A Study Based on Qualitative Systemic Approach.Lipid profiles and inflammatory markers after periodontal treatment in children with congenital heart disease and at risk for atherosclerosis.Evidence that periodontal treatment improves biomarkers and CVD outcomes.Cardioprotective effect of mumie (shilajit) on experimentally induced myocardial injury.Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.Evidence that periodontal treatment improves biomarkers and CVD outcomes.
P2860
Q28393421-03CACE90-24B8-4AF5-93AA-56EEB02F9E06Q34182258-B40A25EA-1819-46E9-906C-C8DDF646F5FDQ35690502-01455C6D-F23A-4EBE-A5E1-D672D8D75174Q37313123-BBBB2657-4679-4E88-A1ED-F5ECBFE82CEAQ38102723-9C4152BB-EA1D-4FC2-A386-A6AFD959F161Q47678747-4F9E2440-B926-49C2-9898-96681F1D08A9Q47767547-C3778578-54FC-40C2-9D9D-2A64F91302A5Q51029740-AD566A97-80E6-4E7A-9838-E92C8322249D
P2860
Cardiovascular disease: rise, fall, and future prospects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiovascular disease: rise, fall, and future prospects.
@en
Cardiovascular disease: rise, fall, and future prospects.
@nl
type
label
Cardiovascular disease: rise, fall, and future prospects.
@en
Cardiovascular disease: rise, fall, and future prospects.
@nl
prefLabel
Cardiovascular disease: rise, fall, and future prospects.
@en
Cardiovascular disease: rise, fall, and future prospects.
@nl
P1476
Cardiovascular disease: rise, fall, and future prospects.
@en
P2093
Russell V Luepker
P356
10.1146/ANNUREV-PUBLHEALTH-112810-151726
P577
2011-01-01T00:00:00Z